ArticleHealth research policy and systems2026
Global partnerships for local impact: Strengthening HTA capacity in Asia and Africa through collaborative experiences.
Article in Health research policy and systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHealth technology assessment (HTA) is recognized as a critical tool for informing health policy decisions and advancing sustainable universal health coverage (UHC). For over a decade, the Health Intervention and Technology Assessment Program Foundation (HITAP) has undertaken systematic efforts to strengthen HTA capacity across Asia and Africa. This study reviews HITAP's experience in capacity strengthening to inform strategies for effective international collaboration and capacity-building in low- and middle-income countries.
methodsA document review of HITAP's capacity-strengthening initiatives from 2010 to mid-2025 was conducted using HITAP's internal documentation. Initiatives were categorized according to the Individual, Node, Network and Environment (INNE) framework and by activity type, with data analyzed descriptively. In addition, key informant interviews (KII) were conducted with key HTA decision-makers from 7 countries who had prior engagement with HITAP, and thematic analysis was applied to the KII data.
resultsA total of 278 HTA capacity-strengthening activities across 25 countries were identified from 2010 to mid-2025. The majority of the initiatives (n = 151) were with countries in Asia, were programmatic (n = 128) instead of ad hoc and involved mostly knowledge sharing (26%) and research and project collaborations (21%). Out of 11 countries in Africa, only 3 had programmatic engagements with HITAP (n = 30), involving mostly advising and mentoring (30%). Analysis of annual activity frequency shows that, in the post-pandemic period (2022 onwards), multi-country engagements have increased as collaborative activities have transitioned to include a larger number of countries within a single event. KII participants reported that these collaborations enhanced awareness and recognition of HTA among key stakeholders including policy-makers, strengthened technical capacity within the Ministry of Health and partner organizations, and generated outputs such as HTA guidelines, publications, dedicated HTA units, a Memorandum of Understanding and institutional or regulatory reforms at all 4 INNE levels.
conclusionsCollaborations for strengthening capacity for HTA are critical and will shape the next decades as countries strive to achieve and sustain UHC. Contextual approaches, underpinned by a multi-pronged approach, with an emphasis on joint initiatives across countries, are needed to ensure HTA remains relevant and responsive to evolving priorities in the changing international context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.